Glazer Capital LLC’s Centessa Pharmaceuticals CNTA Stock Holding History

Glazer Capital LLC’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-325,001	Closed	-$12.9M	–	556
2026 Q1	$12.9M	Buy	+325,001	New	+$8.31M	0.27%	61

Glazer Capital LLC's CNTA Position: Q2 2026 in Review

Glazer Capital LLC sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 325,001 shares — an estimated $12.9M sold.

Glazer Capital LLC first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $12.9M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Glazer Capital LLC reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Glazer Capital LLC sold 325,001 Centessa Pharmaceuticals shares in Q2 2026, an estimated $12.9M.
Glazer Capital LLC first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Glazer Capital LLC's Centessa Pharmaceuticals position peaked at $12.9M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Glazer Capital LLC's 13F filing for Q2 2026, filed 17 Aug 2026.